Answers are grounded in this paper and cite their sources.
expression in PDAC positively correlates with markers of fibrosis and immunosuppression and predicts poor patient survival. We found that PAI-1 pharmacological inhibition strongly enhances chemo- and immunotherapeutic response against PDAC, increasing survival of mice. Thus, our results unveil ACSL3-PAI-1 signaling as a requirement for PDAC progression with druggable attributes.
No takes yet. Share an insight, caveat, or question.
Sebastiano et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: